Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

United Drug plc (UN6A) - Financial and Strategic SWOT Analysis Review

VIEWS: 33 PAGES: 36

United Drug plc (United Drug) is a provider of outsourced commercial solutions to healthcare companies. It offers supply chain, packaging, sales and marketing, medical and regulatory services to healthcare manufacturers and pharmaceutical retailers. The company carries out its operations in three divisions, namely, Health care Supply Chain, Packaging and Specialty and Sales, Marketing and Medical services.

More Info
									       United Drug plc (UN6A) - Financial and Strategic SWOT Analysis Review
        Reference Code: GDME9381FSA                                                                                           Publication Date: MAR 2013

          United Drug House, Magna Drive,
                                                             Phone              +353 1 4632300                  Revenue          1,746.45 (million EUR)
          Magna Business Park
          Dublin, Dublin                                     Fax                +353 1 4596893                  Net Profit       36.42 (million EUR)
          24                                                 Website            www.united-drug.com             Employees        4,543 (Estimated)
                                                                                UN6A    [Irish       Stock
          Ireland                                            Exchange                                           Industry         Medical Equipment
                                                                                Exchange]

       Company Overview
       United Drug plc (United Drug) is a provider of outsourced commercial solutions to healthcare companies. It offers supply chain,
       packaging, sales and marketing, medical and regulatory services to healthcare manufacturers and pharmaceutical retailers. The
       company carries out its operations in three divisions, namely, Health care Supply Chain, Packaging and Specialty and Sales,
       Marketing and Medical services.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      United Drug plc, SWOT Analysis
         Liam FitzGerald                     Chief Executive Officer                  Strengths                              Weaknesses
         Barry McGrane                       Director
                                                                                      Strong Market Presence                 Declining Cash Reserves
         Chris Corbin                        Director
                                                                                      Constant Growth in Revenues            Lack of Geographic Diversity
         Alan Ralph                          Director
         Peter Gray                          Chairman
        Source: Annual Report, Company Website, Primary and Secondary
                                                                                      Opportunities                          Threats
        Research, GlobalData
                                                                                      Favorable Demographic Trend Intense Competition
       Share Data
                                                                                      Global Pharmaceutical Market           Industry Consolidation
         United Drug plc
                                                                                                                             Challenges
        Share Price (EUR) as on 03-Oct-                                   0.0
        2012
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
        EPS (EUR)                                                        0.15        GlobalData
        Market Cap (million EUR)                                          0.0
        Enterprise Value (million EUR)                                    NA
        Shares Outstanding (million)                                     239
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      Jan 11, 2013         United Drug Reports Revenue Of €1.8 Billion
                                                                                                           In Fiscal 2012
                                                                                      Aug 23, 2012         United Drug Files Motion To Dismiss Legal
                                                                                                           Action By Catalent Pharma
                                                                                      Feb 07, 2012         United Drug Reports Revenue Of €894.2m In
                                                                                                           H1 Fiscal 2012
                                                                                      Jan 06, 2012         United Drug Reports Revenue Of €1.75 Billion
                                                                                                           In Fiscal 2011
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




United Drug plc (UN6A) - Financial and Strategic SWOT Analysis                                                                  Reference Code: GDME9381FSA
Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       United Drug plc - Key Facts................................................................................................................................................................ 5
       United Drug plc - Key Employees....................................................................................................................................................... 6
       United Drug plc - Key Employee Biographies..................................................................................................................................... 7
       United Drug plc - Major Products and Services .................................................................................................................................. 8
       United Drug plc - History .................................................................................................................................................................... 9
       United Drug plc - Company Statement ............................................................................................................................................. 11
       United Drug plc - Locations And Subsidiaries .................................................................................................................................. 13
          Head Office ................................................................................................................................................................................... 13
          Other Locations & Subsidiaries ..................................................................................................................................................... 13
       Section 2 – Company Analysis ......................................................................................................................................................... 15
       United Drug plc - Business Description ............................................................................................................................................ 15
       United Drug plc - Corporate Strategy ............................................................................................................................................... 16
       United Drug plc - SWOT Analysis .................................................................................................................................................... 17
          SWOT Analysis - Overview........................................................................................................................................................... 17
          United Drug plc - Strengths........................................................................................................................................................... 17
             Strength - Strong Market Presence ........................................................................................................................................... 17
             Strength - Constant Growth in Revenues .................................................................................................................................. 17
             Strength - Diversified Business Operations ............................................................................................................................... 17
          United Drug plc - Weaknesses ..................................................................................................................................................... 17
             Weakness - Declining Cash Reserves ...................................................................................................................................... 17
             Weakness - Lack of Geographic Diversity................................................................................................................................. 18
          United Drug plc - Opportunities ..................................................................................................................................................... 18
             Opportunity - Favorable Demographic Trend ............................................................................................................................ 18
             Opportunity - Global Pharmaceutical Market............................................................................................................................. 18
             Opportunity - Growing Outsourcing Market ............................................................................................................................... 18
             Opportunity - Inorganic Growth Strategy ................................................................................................................................... 18
          United Drug plc - Threats .............................................................................................................................................................. 19
             Threat - Intense Competition ..................................................................................................................................................... 19
             Threat - Industry Consolidation Challenges .............................................................................................................................. 19
             Threat - Stringent Government Regulations .............................................................................................................................. 19
       United Drug plc - Key Competitors ................................................................................................................................................... 20
       Section 3 – Company Financial Ratios ............................................................................................................................................. 21
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 21
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 21
       Performance Chart ........................................................................................................................................................................... 23
       Financial Performance...................................................................................................................................................................... 23
       Financial Ratios - Interim Ratios....................................................................................................................................................... 24
       Financial Ratios - Ratio Charts ......................................................................................................................................................... 25
       Section 4 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 26
          United Drug plc, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 ................................................................... 26
          United Drug plc, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 ................................................................... 27


United Drug plc (UN6A) - Financial and Strategic SWOT Analysis                                                                                                  Reference Code: GDME9381FSA
Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
          United Drug plc, Medical Equipment, Deals By Year, 2007 to YTD 2013 ..................................................................................... 28
          United Drug plc, Medical Equipment, Deals By Type, 2007 to YTD 2013................................................................
								
To top